Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters











Database
Language
Publication year range
1.
Am J Physiol Renal Physiol ; 281(4): F693-706, 2001 Oct.
Article in English | MEDLINE | ID: mdl-11553517

ABSTRACT

The immunosuppressive effect of rapamycin is mediated by inhibition of interleukin-2-stimulated T cell proliferation. We report for the first time that rapamycin also inhibits growth factor-induced proliferation of cultured mouse proximal tubular (MPT; IC(50) ~1 ng/ml) cells and promotes apoptosis of these cells by impairing the survival effects of the same growth factors. On the basis of these in vitro data, we tested the hypothesis that rapamycin would impair recovery of renal function after ischemic acute renal failure induced in vivo by renal artery occlusion (RAO). Rats given daily injections of rapamycin or vehicle were subjected to RAO or sham surgery. Rapamycin had no effect on the glomerular filtration rate (GFR) of sham-operated animals. In rats subjected to RAO, GFR fell to comparable levels 1 day later in vehicle- and rapamycin-treated rats (0.25 +/- 0.08 and 0.12 +/- 0.05 ml. min(-1). 300 g(-1), respectively) (P = not significant). In vehicle-treated rats subjected to RAO, GFR increased to 0.61 +/- 0.08 ml. min(-1). 300 g(-1) on day 3 (P < 0.02 vs. day 1) and then rose further to 0.99 +/- 0.09 ml. min(-1). 300 g(-1) on day 4 (P < 0.02 vs. day 3). By contrast, GFR did not improve in rapamycin-treated rats subjected to RAO over the same time period. Rapamycin also increased apoptosis of tubular cells while markedly reducing their proliferative response after RAO. Furthermore, rapamycin inhibited activation of 70-kDa S6 protein kinase (p70(S6k)) in cultured MPT cells as well as in the renal tissue of rats subjected to RAO. We conclude that rapamycin severely impairs the recovery of renal function after ischemia-reperfusion injury. This effect appears to be due to the combined effects of increased tubular cell loss (via apoptosis) and profound inhibition of the regenerative response of tubular cells. These effects are likely mediated by inhibition of p70(S6k).


Subject(s)
Acute Kidney Injury/drug therapy , Apoptosis/physiology , Immunosuppressive Agents/pharmacology , Kidney Tubules, Proximal/cytology , Sirolimus/pharmacology , Acute Kidney Injury/pathology , Adenosine Triphosphate/metabolism , Animals , Antineoplastic Agents/toxicity , Apoptosis/drug effects , Cell Cycle/drug effects , Cell Cycle/physiology , Cell Survival/drug effects , Cell Survival/physiology , Cells, Cultured , Cisplatin/toxicity , Enzyme Activation/drug effects , Epidermal Growth Factor/pharmacology , Glomerular Filtration Rate/drug effects , Kidney Transplantation , Kidney Tubules, Proximal/drug effects , Kidney Tubules, Proximal/metabolism , Lysophospholipids/pharmacology , Mice , Mice, Inbred C57BL , Nephrectomy , Recovery of Function/drug effects , Reperfusion Injury/drug therapy , Reperfusion Injury/pathology , Ribosomal Protein S6 Kinases/antagonists & inhibitors , Ribosomal Protein S6 Kinases/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL